HealthcarePharmaceuticals & BiotechnologyPharmaceuticals

Jagsonpal Pharmaceuticals Ltd

Showing the latest 10 filings. Sign in to filter or browse the full history.

10 of 61 filings·Updated 24 Aug 2026

24 Aug 20262 filings

Company UpdateGeneral

Jagsonpal Pharmaceuticals Allots 27,950 ESOP Shares; paid-up capital increases to Rs 13.19 crore

ESOP allotment and capital impact

27,950 equity shares allotted under JPL ESOP 2022 to eligible employees on exercise.
Shares rank pari-passu with existing equity shares.
Paid-up capital increased to Rs 13,19,14,840.
Total issued shares after issue: 6,59,57,420.
Date of issue: August 24, 2026.
Exercise prices per share: 94.00, 113.60, 115.60.
Premium per share: 92.00, 111.60, 113.60.
ISIN: INE048B01035.

Filed 11:56View Source

Company UpdateAllotment of ESOP / ESPS

Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022

Filed 11:53View Source

12 Aug 20262 filings

Company UpdateCopy of Newspaper Publication

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication on 47th Annual General Meeting (AGM) of the Company to be held on September 18, 2026.

Filed 17:00View Source

Company UpdateNewspaper Publication

Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18, 2026

Filed 16:58View Source

30 Jul 20262 filings

Company UpdateCopy of Newspaper Publication

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Filed 17:24View Source

Company UpdateNewspaper Publication

Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026

Filed 17:20View Source

29 Jul 20261 filing

Company UpdateAllotment of ESOP / ESPS

Intimation for grant of Employee Stock Options

Filed 18:32View Source

17 Jul 20262 filings

Company UpdateGeneral

Jagsonpal completes 85% equity stake acquisition in Aequitas Healthcare Private Limited

Acquisition completed

Jagsonpal completes acquisition of 85% equity stake in Aequitas Healthcare Private Limited.
Disclosures reference earlier intimation dated 29 June, 7 July, and 8 July 2026.
No consideration amount disclosed in the filing.

Filed 16:54View Source

Company UpdateGeneral

Jagsonpal completes 85% acquisition of Aequitas Healthcare Private Limited

Acquisition completion

Jagsonpal has completed acquiring 85% equity stake in Aequitas Healthcare Private Limited.

Filed 16:52View Source

15 Jul 20261 filing

Company UpdateAllotment of ESOP / ESPS

Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022.

Filed 16:39View Source

Showing 10 of 61 filings